- Home
- HBIO vs DARE Comparison
HBIO vs DARE Comparison
Compare HBIO & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- DARE
- Stock Information
- Founded
- HBIO 1901
- DARE 2015
- Country
- HBIO United States
- DARE United States
- Employees
- HBIO N/A
- DARE N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- DARE Health Care
- Exchange
- HBIO Nasdaq
- DARE Nasdaq
- Market Cap
- HBIO 24.6M
- DARE 28.6M
- IPO Year
- HBIO 2000
- DARE N/A
- Fundamental
- Price
- HBIO $0.52
- DARE $1.82
- Analyst Decision
- HBIO Buy
- DARE Strong Buy
- Analyst Count
- HBIO 3
- DARE 2
- Target Price
- HBIO $2.50
- DARE $10.00
- AVG Volume (30 Days)
- HBIO 18.1M
- DARE 184.6K
- Earning Date
- HBIO 11-06-2025
- DARE 11-14-2025
- Dividend Yield
- HBIO N/A
- DARE N/A
- EPS Growth
- HBIO N/A
- DARE N/A
- EPS
- HBIO N/A
- DARE N/A
- Revenue
- HBIO $88,750,000.00
- DARE N/A
- Revenue This Year
- HBIO N/A
- DARE $5,401.89
- Revenue Next Year
- HBIO $7.02
- DARE $6,257.18
- P/E Ratio
- HBIO N/A
- DARE N/A
- Revenue Growth
- HBIO N/A
- DARE N/A
- 52 Week Low
- HBIO $0.28
- DARE $1.80
- 52 Week High
- HBIO $2.82
- DARE $9.19
- Technical
- Relative Strength Index (RSI)
- HBIO 54.48
- DARE 31.98
- Support Level
- HBIO $0.48
- DARE $1.80
- Resistance Level
- HBIO $0.65
- DARE $2.03
- Average True Range (ATR)
- HBIO 0.08
- DARE 0.09
- MACD
- HBIO 0.02
- DARE -0.03
- Stochastic Oscillator
- HBIO 24.98
- DARE 5.00
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.